Publication | Closed Access
Characterization of JNJ-80948543, a Novel CD79bxCD20xCD3 Trispecific T-Cell Redirecting Antibody for the Treatment of B-Cell Non-Hodgkin Lymphoma
21
Citations
0
References
2022
Year
Lymphoid NeoplasiaAutoimmune DiseaseHematologyImmunologyPathologyB-cell Non-hodgkin LymphomaAdult T-cell Leukemia-lymphomaImmunotherapyMedicine
No additional data available for this publication yet. Check back later!